A Novel Epithelial-Mesenchymal Transition Gene Signature Correlated With Prognosis, and Immune Infiltration in Hepatocellular Carcinoma

被引:6
|
作者
Kong, Weihao
Mao, Zhongxiang
Han, Chen
Ding, Zhenxing
Yuan, Qianqian
Zhang, Gaosong
Li, Chong
Wu, Xuesheng
Chen, Jia
Guo, Manyu
Hong, Shaocheng
Yu, Feng
Liu, Rongqiang
Wang, Xingyu
Zhang, Jianlin
机构
[1] Department of Emergency Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei
[2] Registration Review Department, Anhui Center for Drug Evaluation & Inspection, Hefei
[3] Department of Emergency Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei
[4] Department of Biochemistry & Molecular Biology, School of Basic Medicine, Anhui Medical University, Hefei
[5] Department Ultrasound, The First Affiliated Hospital of Anhui Medical University, Hefei
[6] The First Clinical Medical College, Anhui Medical University, Anhui Medical University, Hefei
[7] Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou
关键词
epithelial-mesenchymal transition; gene signature; TCGA; GEO; ICGC; hepatocellular carcinoma; R PACKAGE; METAANALYSIS;
D O I
10.3389/fphar.2022.863750
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Although many genes related to epithelial-mesenchymal transition (EMT) have been explored in hepatocellular carcinoma (HCC), their prognostic significance still needs further analysis.Methods: Differentially expressed EMT-related genes were obtained through the integrated analysis of 4 Gene expression omnibus (GEO) datasets. The univariate Cox regression and Lasso Cox regression models are utilized to determine the EMT-related gene signature. Based on the results of multivariate Cox regression, a predictive nomogram is established. Time-dependent ROC curve and calibration curve are used to show the distinguishing ability and consistency of the nomogram. Finally, we explored the correlation between EMT risk score and immune immunity.Results: We identified a nine EMT-related gene signature to predict the survival outcome of HCC patients. Based on the EMT risk score's median, HCC patients in each dataset were divided into high and low-risk groups. The survival outcomes of HCC patients in the high-risk group were significantly worse than those in the low-risk group. The prediction nomogram based on the EMT risk score has better distinguishing ability and consistency. High EMT risk score was related to immune infiltration.Conclusion: The nomogram based on the EMT risk score can reliably predict the survival outcome of HCC patients, thereby providing benefits for medical decisions.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Elevated Preoperative Serum CEA Level Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma Through the Epithelial-Mesenchymal Transition
    Yoshikawa, Masato
    Morine, Yuji
    Ikemoto, Tetsuya
    Imura, Satoru
    Higashijima, Jun
    Iwahashi, Shuichi
    Saito, Yu
    Takasu, Chie
    Yamada, Shinichiro
    Ishikawa, Daichi
    Teraoku, Hiroki
    Takata, Atsushi
    Yoshimoto, Toshiaki
    Shimada, Mitsuo
    ANTICANCER RESEARCH, 2017, 37 (03) : 1169 - 1175
  • [42] Epithelial-Mesenchymal Transition Gene Signature Related to Prognostic in Colon Adenocarcinoma
    Busuioc, Constantin
    Ciocan-Cartita, Cristina Alexandra
    Braicu, Cornelia
    Zanoaga, Oana
    Raduly, Lajos
    Trif, Monica
    Muresan, Mihai-Stefan
    Ionescu, Calin
    Stefan, Cristina
    Crivii, Carmen
    Al Hajjar, Nadim
    Margarit, Simona
    Berindan-Neagoe, Ioana
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (06):
  • [43] Construction and validation of a novel signature based on epithelial-mesenchymal transition-related genes to predict prognosis and immunotherapy response in hepatocellular carcinoma by comprehensive analysis of the tumor microenvironment
    Gao, Biao
    Wang, Yafei
    Lu, Shichun
    FUNCTIONAL & INTEGRATIVE GENOMICS, 2023, 23 (01)
  • [44] GIT1 overexpression promotes epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma
    Wang, Guifu
    Bai, Xuesong
    Jiang, Guoqing
    Jin, Shengjie
    Wang, Qian
    Wang, Aoqing
    Peng, Rui
    Ke, Aiwu
    Bai, Dousheng
    BIOENGINEERED, 2021, 12 (01) : 30 - 43
  • [45] Musashi2 predicts poor prognosis and invasion in hepatocellular carcinoma by driving epithelial-mesenchymal transition
    He, Lu
    Zhou, Xinke
    Qu, Chen
    Hu, Lijuan
    Tang, Yunqiang
    Zhang, Qiong
    Liang, Min
    Hong, Jian
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2014, 18 (01) : 49 - 58
  • [46] Six2 is negatively correlated with prognosis and facilitates epithelial-mesenchymal transition via TGF-β/Smad signal pathway in hepatocellular carcinoma
    Zheng-Hua Wan
    Yun-Han Ma
    Tian-Yi Jiang
    Yun-Kai Lin
    Yuan-Yuan Shi
    Ye-Xiong Tan
    Li-Wei Dong
    Hong-Yang Wang
    Hepatobiliary & Pancreatic Diseases International, 2019, 18 (06) : 525 - 531
  • [47] Six2 is negatively correlated with prognosis and facilitates epithelial-mesenchymal transition via TGF-β/Smad signal pathway in hepatocellular carcinoma
    Wan, Zheng-Hua
    Ma, Yun-Han
    Jiang, Tian-Yi
    Lin, Yun-Kai
    Shi, Yuan-Yuan
    Tan, Ye-Xiong
    Dong, Li-Wei
    Wang, Hong-Yang
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2019, 18 (06) : 525 - 531
  • [48] A novel prognostic models for identifying the risk of hepatocellular carcinoma based on epithelial-mesenchymal transition-associated genes
    Xiong, Chen
    Wang, Guifu
    Bai, Dousheng
    BIOENGINEERED, 2020, 11 (01) : 1034 - 1046
  • [49] Prognostic Analysis of Hepatocellular Carcinoma With Hepatitis C Virus Infection Using Epithelial-Mesenchymal Transition Gene Profiles
    Ueno, Masaki
    Kawai, Manabu
    Park, Jin-Young
    Hirono, Seiko
    Okada, Ken-ichi
    Hayami, Shinya
    Wang, Hee-Jung
    Yamaue, Hiroki
    JOURNAL OF SURGICAL RESEARCH, 2020, 245 : 302 - 308
  • [50] Genomics and prognosis analysis of epithelial-mesenchymal transition in colorectal cancer patients
    Zizhen Zhang
    Sheng Zheng
    Yifeng Lin
    Jiawei Sun
    Ning Ding
    Jingyu Chen
    Jing Zhong
    Liuhong Shi
    Meng Xue
    BMC Cancer, 20